Bioventus Inc (BVS)
11.24
-0.04
(-0.31%)
USD |
NASDAQ |
Nov 07, 16:00
11.24
0.00 (0.00%)
After-Hours: 20:00
Bioventus Revenue (Annual): 512.34M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 512.34M |
| December 31, 2022 | 512.12M |
| December 31, 2021 | 430.90M |
| December 31, 2020 | 321.16M |
| December 31, 2019 | 340.14M |
| Date | Value |
|---|---|
| December 31, 2018 | 319.18M |
| December 31, 2015 | 253.65M |
| December 31, 2014 | 242.89M |
| December 31, 2013 | 232.38M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
321.16M
Minimum
2020
512.34M
Maximum
2023
423.33M
Average
430.90M
Median
2021
Revenue (Annual) Benchmarks
| Boston Scientific Corp | 14.24B |
| Insulet Corp | 1.697B |
| Perspective Therapeutics Inc | -- |
| Xtant Medical Holdings Inc | 91.30M |
| Catheter Precision Inc | 0.442M |